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RUNX3 functions as a tumor suppressor in the
gastric epithelium, where its inactivation is frequently
observed during carcinogenesis. We identified IL23A
as a RUNX3 target gene in gastric epithelial cells. This
was confirmed in a series of in vitro analyses in gastric
epithelial cell lines. In elucidating the underlying regu-
latory network, we uncovered a prominent role for the
TNF-a/NF-kB pathway in activating IL23A transcrip-
tion. Moreover, the activating effect of TNF-a was
markedly augmented by the infection ofHelicobacter
pylori, the primary cause of human gastritis. Of note,
H. pylori utilized the CagA/SHP2 pathway to activate
IL23A, as well as the induction of the NOD1 pathway
by iE-DAP. Importantly, RUNX3 synergized strongly
with these physiologically relevant stimuli to induce
IL23A. Lastly, we present evidence for the secretion
of IL23A by gastric epithelial cells in a form that is
distinct from canonical IL-23 (IL23A/IL12B).INTRODUCTION
In the stomach, persistent infection by the gastric pathogen
Helicobacter pylori and the ensuing inflammation is the single
greatest risk factor for gastric neoplasia (Fox and Wang, 2007).
While much is known of the mechanisms and consequences of
H. pylori infection, little is known of the innate immunity within
gastric epithelial cells that acts as the host’s foremost defense
(Monack et al., 2004).
Innate immunity in the mucosa is founded on a tissue niche of
epithelial, stromal, and hematopoietic cells, where cell-to-cell
communication is dependent on a complex network of immune
signaling. Of prime importance is the NF-kB pathway, which
plays a cardinal role inmediating tissue inflammation in response
to pathogen infection, physical insults, and proinflammatory cy-
tokines, such as tumor necrosis factor a (TNF-a) and interleukin-
1 (IL-1) (Jobin and Sartor, 2000). A key epithelial response to
H. pylori infection is the secretion of the chemokine IL-8, which50 Cell Reports 8, 50–58, July 10, 2014 ª2014 The Authorsrecruits leukocytes for the prompt clearance of pathogens
(Censini et al., 1996). While IL-8 is an important component
of host response against infection, the full range of immune sig-
nals released by infected gastric epithelial cells remains to be
determined.
As the causative relationship between inflammation and can-
cer becomes increasingly established, evidence has emerged
that classical tumor suppressors can influence inflammation
and immunity through crosstalk, such as those between the
p53 andNF-kBpathways (Baldwin, 2012). The Runt-related tran-
scription factor RUNX3 is a well-established tumor suppressor in
the gastric epithelium, where its inactivation is observed in up to
80% of primary gastric tumors (Ito et al., 2005; Li et al., 2002).
In mice, genetic ablation of Runx3 leads to the development of
spasmolytic polypeptide expressing metaplasia (SPEM), a pre-
neoplastic condition often associated with H. pylori infection in
humans (Ito et al., 2011). In addition to these epithelial cell-auton-
omous functions, Runx3 is a key player in hematopoiesis and,
together with Runx1, is essential for the proper differentiation
and functioning of T cells, B cells, natural killer cells, andmyeloid
lineages (Collins et al., 2009; Levanon et al., 2014; Puig-Kro¨ger
and Corbı´, 2006; Watanabe et al., 2010).
In this study, we describe a role for RUNX3 in the direct regu-
lation of IL23A in strong cooperation with TNF-a/NF-kB and
H. pylori infection in gastric epithelial cells. Our data further
suggest the secretion of IL23A in a form that appears distinct
from canonical IL23A/IL12B. Consistent with these findings,
we detect the expression of IL23A, independent of IL12B, in pu-
rified human primary gastric epithelial cells. These findings impli-
cate IL23A to be a component of the epithelial innate immune
response, whose expression is strongly dependent on the tumor
suppressor RUNX3.
RESULTS
IL23A Is Transcriptionally Regulated by RUNX3 in
Gastric Epithelial Cells
In an expression microarray study, IL23A was identified as
a putative target gene of RUNX3 in AGS gastric carcinoma
cells (J.K.W.K., D.C.-C.V., and Y.I., unpublished data). This
was confirmed in a number of RUNX3-negative human gastric
Figure 1. IL23A Is Transcriptionally Regu-
lated by RUNX3 in Gastric Epithelial Cells
(A) IL23A mRNA expression was induced by
exogenous RUNX3 in multiple RUNX3-negative
gastric cancer cell lines. GFP-positive transfected
cells were enriched by FACS at 24 hr and 48 hr
posttransfection and analyzed by qRT-PCR.
Normalized IL23A levels are expressed relative to
untransfected control values.
(B) RUNX3 specifically induced IL23A in gastric
epithelial cells. AGS cells transduced with the
indicated viruses were analyzed by qRT-PCR for
the expression of the IL-12 family of cytokine
genes. Normalized data are presented relative to
the Lenti-control sample (mean ±SEM; n = 3) (u.d.,
undetected).
(C) RUNX3 mediates its effect through the prox-
imal RUNX sites B, C, andDof the IL23A promoter.
Mutation and deletion variants of the IL23A-1200
reporter construct were transiently transfected
into KATOIII cells together with either control or
RUNX3 expression vectors. Normalized luciferase
activities are expressed relative to the values of
control samples for each construct. Data pre-
sented are derived from independent biological
triplicates (mean ± SEM).
(D) Physical occupancy of RUNX3 on the
IL23A promoter in Lenti-RUNX3-transduced AGS
cells was detected by ChIP analysis using poly-
clonal or monoclonal RUNX3-specific antibodies.
Enrichment of the indicated genomic fragments
was detected by qPCR (Table S1) and expressed
relative to input DNA. Nonspecific immunoglobulin
G from rabbit (rIgG) and mouse (mIgG) served as
negative controls; H3K9Ace antibody was used
as a positive control. NS, nonspecific region;
pAb, polyclonal antibody; mAbs, monoclonal an-
tibodies. *p < 0.05; **p < 0.01.
See also Figure S1.carcinoma lines, demonstrating an important role for RUNX3
(Figure 1A). To investigate if RUNX3 acts transcriptionally
on IL23A and whether it has similar effects on other IL-12
family members, AGS cells were transduced with lentivir-
uses expressing wild-type RUNX3 or DNA-binding-defective
RUNX3R178Q (hereafter Lenti-RUNX3 and Lenti-RUNX3R178Q)
and analyzed by quantitative RT-PCR (qRT-PCR). This revealed
that RUNX3 specifically induced the expression of IL23A in
a DNA-binding-dependent manner while having no effect on
other IL-12 family members (Figure 1B). Of note, the expression
of IL12A, IL27A, and IL12B was very low or undetectable in
this cell type (Figure 1B). To study the molecular mechanism
underlying the induction of IL23A, a promoter fragment span-
ning 1,200 to +105 of the IL23A locus (Figure S1A) was
cloned into a firefly reporter construct (hereafter IL23A-1200 re-
porter). Transient transfection of IL23A-1200 reporter, together
with an expression vector encoding RUNX3, into KATOIII and
other gastric lines resulted in an induction in luciferase activity,
indicating that the cloned promoter fragment recapitulates thetransactivating effect of RUNX3 (Figure 1C). By a combination
of sequence analysis and empirical mapping, it was determined
that three proximal RUNX sites, two of which are noncanoni-
cal, are necessary for RUNX3’s transactivation of the IL23A
promoter (Figure 1C; Figures S1B and S1C). Notably, the non-
canonical site D appeared particularly important for the full ef-
fects of RUNX3, while the distal site A appeared nonfunctional
(Figure S1C).
To demonstrate the in vivo occupancy of these functional sites
by RUNX3, chromatin immunoprecipitation (ChIP) assays were
performed on AGS cells that had been transduced with Lenti-
RUNX3 (Figure 1D). Polyclonal and monoclonal RUNX3 anti-
bodies strongly enriched genomic DNA fragments bearing sites
B, C, and D. Consistent with reporter assay data, genomic frag-
ments bearing site Awere not significantly enriched. Similarly, no
enrichment by RUNX3-specific antibodies was observed for
regions that contain no RUNX sites (Figure 1D). Comparable
results were obtained in HFE-145, an untransformed gastric
epithelial line, as well as in THP-1, a myeloid cell line in whichCell Reports 8, 50–58, July 10, 2014 ª2014 The Authors 51
Figure 2. RUNX3 Augments TNF-a Induc-
tion of IL23A Expression
(A and B) The effects of various proinflammatory
stimuli on the expression of IL23A. AGS cells were
treated with the indicated (A) cytokines and (B)
ligands and agonists of various TLRs and NLRs for
6 hr prior to qRT-PCR measurement of IL23A
transcript. Normalized IL23A mRNA levels are
expressed relative to that of untreated controls
(Mock). Data presented are derived from biolog-
ical triplicates (mean ± SEM).
(C) Cooperative induction of IL23A by RUNX3 and
TNF-a. AGS cells were transduced with the indi-
cated lentiviruses for 48 hr and treated with TNF-a
for 6 hr for qRT-PCR analysis (top) or 18 hr for
western blot analysis (bottom). Top: normalized
IL23AmRNA levels are plotted relative to the basal
values of Lenti-control-infected cells (mean ±
SEM; n = 3). Bottom: whole-cell lysates were
analyzed for IL23A, RUNX3, and a-tubulin (loading
control) expression by western blotting.
(D and E) Sequence requirement for TNFa induc-
tion of IL23A promoter. Wild-type and mutant
variants of the IL23A promoter reporter constructs
were transiently transfected into the cells together
with either control or RUNX3 expression vector
for 24 hr followed by TNF-a treatment for 24 hr.
Normalized luciferase activities are presented
relative to those of untreated control samples
(mean ± SEM; n = 3). *p < 0.05; **p < 0.01.
See also Figure S2.IL23A could be strongly induced by lipopolysaccharide (LPS)
(Figures S1D–S1F). Taken together, these cellular and biochem-
ical data provide strong evidence that RUNX3 transactivates
IL23A promoter in gastric epithelial cells through its direct bind-
ing to sites B, C, and D.
RUNX3 Augments TNF-a Induction of IL23A Expression
To evaluate the participation of NF-kB, STAT3, and SMAD3,
which are known to regulate IL23A in myeloid cells, AGS gastric
epithelial cells were treated with stimuli upstream of these tran-
scription factors. This resulted in the clear induction of IL23A by
TNF-a, IL-1a, and IL-1b, indicating the involvement of NF-kB
(Figure 2A). In contrast, interferon-g (IFN-g), IL-6, and TGF-b
had no effect on IL23A expression (Figure 2A). A role for NF-kB
is further supported by the significant induction of IL23A
mRNA by the NOD1 agonist D-glutamyl-meso-diaminopimelic
acid (iE-DAP) (Figure 2B). Interestingly, IL23A expression in
AGS and SNU16 cells was refractory to LPS, a potent inducer52 Cell Reports 8, 50–58, July 10, 2014 ª2014 The Authorsof IL23A in THP-1 cells, and all other
TLR/NLR agonists tested (Figure 2B;
Figures S1F and S2).
To further understand the relationship
between RUNX3 and TNF-a, AGS cells
were transduced with Lenti-RUNX3 and
Lenti-RUNX3R178Q and treated with TNF-
a. The ectopic expression of RUNX3, but
not RUNX3R178Q, markedly augmented
TNF-a induction of IL23AmRNA and pro-tein (Figure 2C). To demonstrate that the partnership between
TNF-a andRUNX3occurs at the level of transcriptional activation,
reporter assays were performed. This revealed that the activating
effects of TNF-a on the IL23A-1200 reporter were enhanced
by exogenous RUNX3 in a manner dependent on the proximal
RUNX sites (Figure 2D). In a reciprocal experiment, mutation of
a functional NF-kB site abolished TNF-a responsiveness and
cooperation between RUNX3 and TNF-a (Figure 2E). Further-
more, the mutant construct IL23A-300mkB was less responsive
to RUNX3, suggesting that RUNX3’s action is partly dependent
on binding of NF-kB (Figure 2E). Together, these data demon-
strate a functional cooperation between RUNX3 and NF-kB in
the transactivation of IL23A promoter in gastric epithelial cells.
H. pylori Is a Potent Inducer of IL23A inGastric Epithelial
Cells
Intracellular delivery of iE-DAP is a consequence of H. pylori
infection. To ascertain the physiological significance of the
induction of IL23A by iE-DAP (Figure 2B), AGS cells were in-
fected with H. pylori at increasing multiplicity of infection (MOI).
This resulted in a dose-dependent induction of IL23A (Figure 3A).
Notably, heat-killed H. pylori had no effect, which is consistent
with the reliance of an active type IV secretion system (T4SS)
for the intracellular transportation of iE-DAP (Figure 3A). As the
H. pylori oncoprotein CagA is also delivered by the T4SS and
known to activate host gene expression, its effect on IL23A
was also investigated. A comparison in the induction kinetics
of wild-type CagA-positive H. pylori (WT Hp) and its isogenic
CagA-deficient mutant (DCagA Hp) revealed that sustained in-
duction of IL23A in infected cells requires CagA (Figure S3A).
This requirement was confirmed by the strong induction of
IL23A by CagA-proficient H. pylori, but not its DCagA counter-
part, at the later time point of 18 hr (Figure 3B). Importantly,
this induction was completely blocked by an inhibitor of SHP-2
phosphatase (NSC87877), concordant with CagA’s known abil-
ity to utilize the SHP-2/ERK pathway (Figure 3B).
To determine if the effects of H. pylori and TNF-a are
conserved across gastric epithelial cells, a range of immortalized
or transformed gastric epithelial cell lines of various origins was
subjected to treatment. This revealed that IL23A expression was
significantly induced by TNF-a andH. pylori in all cell lines tested,
indicating that the molecular mechanisms underlying their activ-
ities are well conserved and intrinsic to gastric epithelial cells
(Figure 3C).
As TNF-a andH. pylori each play important roles in the etiology
of inflammation-associated gastric cancer, a potential coopera-
tion between these distinct signals andRUNX3was investigated.
Lentivirus-transduced AGS cells were subjected to individual or
combined treatments of TNF-a and H. pylori. As in the case of
TNF-a, expression of exogenous RUNX3, but not RUNX3R178Q,
greatly enhanced the induction of IL23A in response to
H. pylori infection (Figure 3D, top panel). Importantly, cotreat-
ment with TNF-a and H. pylori resulted in stronger induction,
which was further enhanced by wild-type RUNX3. The in-
creases in IL23A expression were confirmed bywestern blotting,
revealing RUNX3 as a critical determinant in cellular response to
TNF-a andH. pylori (Figure 3D, bottom panel). Collectively, these
data indicate that IL23A is part of the host response in gastric
epithelial cells in reaction to inflammation and infection. It also
implicates a role for RUNX3 in orchestrating this response. Of
note, RUNX3’s action appears specific to a distinct subset
of genes, as it had no effect on H. pylori induction of IL8, a
well-established H. pylori target gene (Figure S3B).
As RUNX1 is also expressed in gastric epithelial cells, its ability
to transactivate IL23A promoter was tested. In KATOIII and
SNU16 cells, the cotransfection of a RUNX1 expression vector
resulted in the RUNX sites-dependent induction of IL23A-1200
reporter activities comparable to that of RUNX3 (Figure 3E). To
confirm the participation of both RUNX proteins, RNAi knock-
down of RUNX1 or RUNX3 was performed in HFE-145 cells,
which resulted in weaker induction of IL23A by H. pylori and
TNF-a (Figure 3F; Figures S3C and S3D). Moreover, concurrent
targeting of both RUNX proteins had additive effects, indicating
overlapping and nonredundant functions (Figure 3F). These data
indicate a similarly important role for RUNX1 in the transcrip-
tional regulation of IL23A in response to TNF-a/H. pylori.Epithelial IL23A Is Secreted in a Form Distinct from
Heterodimeric IL-23
IL23A interacts with IL12B to form the heterodimeric IL-23. How-
ever, despite robust expression of IL23A, IL12B is essentially
undetectable by qRT-PCR in all gastric carcinoma lines tested
(data not shown). The absence of IL12B is confirmed by the
inability of two different commercially available ELISA kits to
detect heterodimeric IL-23 (IL23A/IL12B) in the supernatants of
maximally induced AGS cells (Figure 4A) and several TNF-a acti-
vated gastric carcinoma lines (Figure 4B). To ascertain if IL23A is
indeed secreted, we first measured the accumulation of intracel-
lular IL23A in RUNX3-expressing AGS following the inhibition of
protein export by brefeldin A (BFA). This revealed a time-depen-
dent increase in intracellular IL23A protein that peaked within
9 hr of exposure to TNF-a/H. pylori (Figure 4C). Moreover,
a much higher level of intracellular IL23A is accumulated in
RUNX3-expressing cells, compared with those of the control
samples, underscoring the importance of RUNX3 (Figure 4D).
Notably, IL23A accumulation is observed even in unstimulated
RUNX3-expressing cells, indicating the exportation of IL23A
in resting AGS cells (Figure 4D). To demonstrate the secretion
of IL23A, supernatant of AGS cells transduced with a lentivirus
encoding FLAG-tagged recombinant IL23A was subjected to
immunoprecipitation by anti-FLAG antibodies. This resulted in
the enrichment of tagged IL23A from the supernatant of trans-
duced AGS cells (Figure 4E). Together, these data provide evi-
dence for the secretion of IL23A by gastric epithelial cells, albeit
in a form not recognized by canonical IL-23 ELISA kits.
Lastly, human primary gastric epithelial cells harvested from
nonmalignant tissues adjacent to resected primary gastric tu-
mors were analyzed for IL23A expression. The recovered cells
were subjected to fluorescence-activated cell sorting (FACS),
where the CD45+ leukocytic and CD45EpCAM+ epithelial cell
fractions were enriched (Figure 4F). The expression of IL23A
was clearly detected by qRT-PCR in the purified epithelial frac-
tion (Figure 4G). This was unlikely to be caused by contaminating
leukocytes, since CD45 and IL12B were undetectable in this
fraction. These observations in primary cells are consistent
with those made in gastric carcinoma lines, confirming that
IL23A is expressed independent of IL12B in human gastric
epithelial cells.
DISCUSSION
The well-established link between chronic inflammation and
cancer is particularly relevant in the gastrointestinal tract, where
microbial contacts are frequent (Fox and Wang, 2007; Round
and Mazmanian, 2009). In addition to being an important phys-
ical barrier, the epithelial cells in the gastrointestinal tract also
create an immunological barrier that regulates the interactions
of the luminal microbes with the mucosal immune system
(Round and Mazmanian, 2009). In the stomach, the infection
and colonization by H. pylori and the resultant injury to the
epithelial lining are causally linked with chronic gastric inflamma-
tion and cancer (Fox andWang, 2007). Among its highly adapted
strategies, H. pylori delivers into the host cells bacterial pepti-
doglycan (iE-DAP) and cytotoxins like CagA to interfere and
modify host-cell physiology (Odenbreit et al., 2000). These leadCell Reports 8, 50–58, July 10, 2014 ª2014 The Authors 53
Figure 3. H. pylori Is a Potent Inducer of IL23A in Gastric Epithelial Cells
(A) H. pylori activates IL23A in a dose-dependent manner. AGS cells were cocultured with different MOIs of live or heat-killed H. pylori for 6 hr prior to qRT-PCR
quantification of IL23A transcript. The normalized values are presented relative to those of uninfected control samples (MOI 0) (mean ± SEM; n = 3).
(B) IL23A induction by H. pylori requires activation of the SHP-2/ERK pathway by oncoprotein CagA. AGS cells were preincubated with 50 mM of SHP-2 inhibitor
(NSC87877) for 3 hr followed by infection with wild-type or DCagA strains of H. pylori at MOI100 or vehicle (Mock) for 18 hr. The normalized values are presented
relative to those of uninfected control samples (mean ± SEM; n = 3).
(C) TNF-a andH. pylori activate IL23A in a diverse range of gastric epithelial cell lines. Transformed and untransformed gastric epithelial cell lines were stimulated
with TNF-a (10 ng/ml) or wild-type H. pylori (MOI100) for 6 hr. IL23AmRNA levels were determined by qRT-PCR and normalized values are presented relative to
values of untreated controls of each cell line (mean ± SEM; n = 3).
(D) The expression of IL23A in response to RUNX3, TNF-a, andH. pylori. AGS cells were transduced with the indicated lentiviruses for 48 hr prior to treatment with
TNF-a and/or H. pylori for 6 hr for qRT-PCR analysis (top) or 18 hr for western blot analysis (bottom). Top: normalized IL23A levels are presented relative to those
of untreated AGS cells infected with Lenti-control virus (mean ± SEM; n = 3). Bottom: whole-cell lysates were analyzed for IL23A, RUNX3 and a-tubulin protein
expression by western blotting.
(E) Both RUNX1 and RUNX3 transactivate the IL23A promoter in gastric epithelial cells. KATOIII and SNU16 were transiently transfected with the IL23A-1200
reporter construct together with the indicated expression vectors for 48 hr. Normalized reporter activities of each construct are plotted relative to the values of
corresponding control samples.
(legend continued on next page)
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to changes such as altered epithelial cell-cell adhesion that facil-
itate colonization (Gebert et al., 2003). Concurrently, gastric
epithelial cells in sensing these perturbations would mount an
innate immune response, which includes the secretion of bacte-
ricidal peptides, chemokines, and proinflammatory cytokines to
initiate inflammation (Censini et al., 1996). Indeed, while persis-
tent and chronic inflammation promotes a vicious cycle of tissue
damage and carcinogenesis, an effective acute inflammation is
key to the eradication of pathogens (Fox andWang, 2007; Round
and Mazmanian, 2009).
This paradox is further reflected in the seemingly conflicting
roles of the NF-kB pathway in immunity and disease. Despite its
well-known contribution to chronic inflammation, autoimmunity,
and cancer, recent studies have revealed that its epithelial func-
tion is unexpectedly protective (Nenci et al., 2007; Shibata
et al., 2010; Zaph et al., 2007). This is attributed in part to NF-
kB’s regulation of cytokines and chemokines, crucial for commu-
nication between epithelial cells and leukocytes. Of particular
relevance, epithelial-specific targeting of IKK-b in the stomach
resulted in defective clearance of H. pylori (Shibata et al., 2010).
Previous studies have shown that RUNX3 exerts its tumor-
suppressor effects by modulating epithelial cell growth and
maintaining epithelial integrity and barrier function (Chuang
et al., 2013). The present study reports the transcriptional
regulation of IL23A by RUNX3 in gastric epithelial cells, which
is requisite for IL23A induction by the TNF-a/NF-kB pathway
and H. pylori. This implicates IL23A as part of a NF-kB-driven
antibacterial response mounted by gastric epithelial cells, as
well as a role for RUNX3 in epithelial innate immunity. Moreover,
the involvement of RUNX3 appears highly selective, as it had
no effect on other IL-12 cytokine family members, nor did it
augment the induction of IL8 by H. pylori.
IL23A mediates its known biological functions by dimerizing
with IL12B to form IL-23, which is a potent proinflammatory cyto-
kine essential for the functions of the IL-17-producing T helper
cells (Th17) (Langrish et al., 2005). Reminiscent of the IKKb
knockout mouse phenotype, while IL23A null mice were pro-
tected against infection-induced inflammation, they succumbed
to infection due to defective clearance, hence demonstrating a
protective function for IL23A (Mangan et al., 2006). Although
the primary source cells of the heterodimeric IL-23 are dendritic
cells and macrophages, IL23A has been detected in other cell
types, including keratinocytes, intestinal epithelial cells, and
most recently gastric epithelial cells (Al-Sammak et al., 2013;
Ciccia et al., 2009; Piskin et al., 2006). In this study, we observed
the highly regulated expression of IL23A transcript and protein in
a wide range of untransformed or transformed gastric epithelial
cells. The secretion of IL23A by this cell type is supported first
by the strong intracellular accumulation of IL23A following BFA
treatment (Figure 4D), and second by the detection of tagged
IL23A in culture supernatant by immunoprecipitation (Figure 4E).
However, heterodimeric IL-23 (IL23A/IL12B) could not be de-
tected by two independent sandwich ELISA kits, including one(F) The effects of RNAi knockdown of RUNX3 and RUNX1 on IL23A expression. HF
RUNX3 siRNA (siRX3), and/or RUNX1 siRNA (siRX1) for 48 hr prior to treatment wi
levels are plotted relative to those of untreated siCtrl sample (mean ± SEM; n = 3
See also Figure S3.that employs distinct IL23A antibodies for capture and detection
(data not shown). As previous studies have established that
IL23A secretion is dependent on heterodimerization (Hunter,
2005; Oppmann et al., 2000), our data are consistent with the
secretion of a noncanonical IL23A complex by gastric epithelial
cells, in which IL23A’s interaction with a yet-unknown partner
has masked epitopes utilized by existing ELISA kits.
Adding to the intrigue, RUNX proteins are also expressed
in myeloid lineages, including dendritic cells and macrophages
(Puig-Kro¨ger and Corbı´, 2006). Indeed, we observed the direct
binding and transcriptional activation of IL23A promoter by
RUNX3 andRUNX1 in ChIP and reporter assays using the human
myeloid cell lines THP-1, U937, and K562 (Figures S1E and S3E).
These data suggest that RUNX proteins may contribute to the
production of distinct forms of IL23A via more than one cell
type in the gastric mucosal microenvironment during inflamma-
tion and infection.
In summary, the current study reports the direct regulation
of IL23A by RUNX3 in gastric epithelial cells, where its expres-
sion and secretion is independent of IL12B. The involvement of
RUNX3 appears particularly important during inflammation and
infection, as it strongly augmented the induction of IL23A by
TNF-a/NF-kB and H. pylori. The identification of this pathway
prompts further investigation into the participation of RUNX3 in
the innate immunity of gastric epithelial cells and its contribution
to pathogen clearance and mucosal homeostasis in vivo.
EXPERIMENTAL PROCEDURES
Cell Culture and Treatments
The human gastric lines AGS, KATOIII, MKN7, MKN28, MKN45, SNU16, NCI-
N87,SNU719, andHFE-145and themonocytic cell lineTHP-1 (TohokuHospital
Paediatrics-1) were maintained in RPMI 1640 medium with 10% fetal bovine
serum (FBS), penicillin/streptomycin, and2mML-glutamine under standard tis-
sue culture conditions. Cells were treated with 50 ng/ml of IFN-g; 10 ng/ml of
TNF-a, IL-1a, IL-1b, or IL-6; 5 ng/ml of TGF-b (Peprotech); 1 mg/ml of LPS,
Zymosan, Pam3CSK4, Poly I:C, R-848; 100 mg/ml of Flagellin, 10 mg/ml of
C12-iE-DAP; or 50 mg/ml of N-glycol MDP (InvivoGen) for 6 hr prior to analyses.
Reporter Gene Assay
The firefly luciferase reporter vector of IL23A-1200 and its variants were con-
structed as described in Supplemental Experimental Procedures. These
reporter constructs were transfected into KATOIII, AGS, SNU16, K562, and
U937 cells together with a variant of phRL-SV40 (Renilla luciferase) (Promega)
and control (empty), RUNX3, or RUNX1 expression constructs using Lipofect-
amine 2000 reagent (Invitrogen) or FuGENE 6 (Promega) for 24–48 hr. Firefly
luciferase activities were measured using the Dual Luciferase Reporter Assay
System (Promega) and normalized against the corresponding Renilla lucif-
erase values.
ChIP Analysis
AGS and HFE-145 cells transduced with Lenti-RUNX3 lentivirus and LPS-
induced THP-1 cells were crosslinked in formaldehyde (1%) and sonicated
to generate chromatin fragments of 500 bp. ChIP assays were performed
with the ChIP Assay Kit (Upstate Biotechnology) using polyclonal (AML2;
Active Motif) and monoclonal (R3-5G4 and R3-6E9; MBL) antibodies against
RUNX3, histone H3K9ac antibody (Abcam), and nonspecific rabbit or mouseE-145 cells were transfected with control small interfering RNA (siRNA) (siCtrl),
thH. pylori and TNF-a for 6 hr and qRT-PCRmeasurements. Normalized IL23A
). *p < 0.05; **p < 0.01.
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Figure 4. Epithelial IL23A Is Secreted in a Form Distinct from Heterodimeric IL-23
(A and B) Absence of heterodimeric IL-23 in gastric epithelial cell culture supernatants. (A) AGS cells were transduced with the indicated lentiviruses for 48 hr prior
stimulation with TNF-a and/or H. pylori for 24 hr. Supernatants were subjected to sandwich ELISA for the quantification of IL-23 secretion. Representative data
from two separate ELISA kits are presented. (B) Multiple gastric cancer cell lines were stimulated with TNF-a for 24 hr before culture supernatants were analyzed
by sandwich ELISA specific for heterodimeric IL-23. Supernatant of THP-1 cells stimulatedwith LPS for 24 hr was included as a positive control (u.d., undetected).
(C) Intracellular accumulation of IL23A following the inhibition of protein export. AGSwas transduced with Lenti-RUNX3 virus for 48 hr prior to TNF-a andH. pylori
stimulation for the indicated times. Brefeldin A (BFA) was added to inhibit protein export 8 hr before each sample was harvested for western blotting analysis,
using a-tubulin as control for protein loading.
(legend continued on next page)
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immunoglobulin G (IgG) (Santa Cruz Biotechnology). The recovered DNA
fragments were analyzed by quantitative PCR (qPCR) using specific oligo-
nucleotide primers (refer to Table S1).
Gene Knockdown by RNAi and Overexpression by Lentiviruses
RNAi-mediated knockdown was accomplished by transfecting 0.2 nmol of
gene-specific siRNA or nontargeting control siRNA (Thermo Scientific) using
jetPRIME (Polyplus-transfection) on HFE-145 cells. For expression of exoge-
nous RUNX3, RUNX3R178Q, and C-terminally tagged IL23A-FLAG, lentiviruses
were prepared as previously described (Voon et al., 2012). For infection, cells
were incubated with virus-containing supernatants for 24 hr and cultured with
normal culture medium for another 24 hr.
qRT-PCR
Total RNAwas extracted using theQIAGENRNeasyMini Kit (QIAGEN) accord-
ing to the manufacturer’s instructions. cDNA was synthesized with the Omni-
script RT kit (QIAGEN) as described by the accompanying protocol. qPCRwas
performed with the Universal PCR Master Mix (Applied Biosystems) using
gene-specific oligonucleotide primers for SYBR Green-based measurements
or TaqMan probes (Applied Biosystems) listed in Table S2. Data were analyzed
on an ABI Prism 7500 real-time PCR system (Applied Biosystems). All gene
expression data were normalized against GAPDH levels.
Protein Isolation and Western Blotting
Equal quantities of whole-cell lysates were resolved in SDS-polyacrylamide
gel and immunoblotted with the following antibodies at their respective
dilutions: anti-RUNX3 (1:1,500; R3-5G4), anti-RUNX1 (1:800; R1-1H9), anti-
IL23A (1:250; eBio473P19, eBioscience), anti-a-tubulin (1:10,000; DM1A,
Sigma-Aldrich), and anti-mouse IgG-horseradish peroxidase (1:5,000; Santa
Cruz). To inhibit protein secretion, cells were treated with 1X BFA solution
(eBioscience) 8 hr prior to harvest.
Preparation of H. pylori
Isogenic wild-type (NCTC11637) and CagA-defective (DCagA) strains of
H. pylori are kind gifts from Dr. Hatakeyama (University of Tokyo, Japan).
These are cultivated on Trypticase soy agars with 5% sheep blood (BD Biosci-
ences) at 37C in a humidified and microaerophilic atmosphere to form col-
onies. Broth cultures were prepared by inoculating colonies into Brucella broth
(Sigma-Aldrich) with 10% FBS for 24 hr. Gastric cancer cell lines were infected
with broth-cultured H. pylori at 100 MOI for indicated periods. For inhibition of
the SHP-2/ERK pathway, cells were pretreated with 50 mM of SHP-2 inhibitor,
NSC87877 (R&D Systems) for 3 hr prior to infection with H. pylori.
ELISA
For measurement of IL-23 in the supernatants harvested from cultured cells,
ELISAwas performed using the Human IL-23 Ready-SET-Go! kit (eBioscience)
and the Human IL23A/p19 ELISA kit (Creative Biomart) as per the manufac-
turer’s instructions. To induce the secretion of IL-23, gastric epithelial cell lines
and the monocytic cell line THP-1 were stimulated with TNF-a, H. pylori, or
LPS for 24 hr.
Immunoprecipitation of FLAG Fusion IL23A
To enrich the FLAG-tagged IL23A in supernatant of AGS cells, immunoprecip-
itation (IP) was performed using mouse anti-FLAG M2 affinity gel (Sigma-
Aldrich) following the manufacturer’s protocol. Supernatant was prepared(D) Intracellular IL23A is greatly induced by BFA in the presence of RUNX3. AGS
with TNF-a and H. pylori for 9 hr. BFA solution was added 8 hr prior to western b
(loading control).
(E) IL23A is secreted by gastric epithelial cells. AGS cells transduced with the
supernatant was subjected to immunoprecipitation by anti-FLAG agarose beads
(F) CD45/EpCAM expression profile of freshly isolated normal primary gastric c
(epithelial) fractions.
(G) Expression of IL23A, but not IL12B, in primary gastric epithelial cells. The expr
and EpCAM+CD45 cells purified from human gastric tissues by qRT-PCR. Norm
higher expression.from AGS cells transduced with lentivirus containing IL23A-FLAG construct.
After 48 hr, cells were stimulated with TNF-a (10 ng/ml) and H. pylori
(MOI100) for 9 hr prior harvesting the supernatant for the IP experiment.
Purification of Human Primary Gastric Epithelial Cells
All patient tissue samples were collected with informed patient consent
from National University Hospital, Singapore, according to institutional review
board guidelines. Resected gastric tissues were washed, minced, and incu-
bated in 0.1% dithiothreitol/PBS to remove mucus. These were then digested
with 100 U/mL hyaluronidase, 300 U/mL collagenase type II, 1 ng/ml hydrocor-
tisone (Sigma-Aldrich), and 5 ng/mL insulin (Invitrogen) for 2 hr in Dulbecco’s
modified Eagle’s medium/F12 (Invitrogen). Following washes and the removal
of clumped and dead cells, cells were resuspended in 2% BSA/Hank’s
balanced salt solution and stained with EpCAM-APC (Miltenyi Biotec) and
CD45-FITC (Biolegend) antibodies and fractionated on a FACS Aria (BD
Biosciences).
Statistical Analysis
All data are presented as mean ± SEM. The Student’s t test was utilized
in comparison of two data sets, where p values of <0.05 are considered
significant.
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